Learn about Immunotherapy and BRI's Work in Seattle Business Magazine


Read the latest on immunotherapy in Seattle Business Magazine --
"Immunotherapy research is rebooting Seattle’s biotech sector. It might even save your life." The potential for immunotherapy to provide a cure extends far beyond cancer. At BRI, scientists are using immunotherapy to target Type 1 diabetes, multiple sclerosis and rheumatoid arthritis. BRI's executive director Homer Lane is quoted. Read more 

Learn the Latest

A sample printed newsletterSign up for our news & updates and learn the latest in the fight against autoimmune diseases.

Sign up today